✦ LIBER ✦

A Prospective Pathologic Study to Define the Clinical Target Volume (CTV) for Partial Breast Radiotherapy in Women with Early Breast Cancer

✍ Scribed by B.T. Nguyen; S. Deb; S. Fox; P. Hill; M. Collins; B. Chua

Book ID: 118455780
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 45 KB
Volume: 81
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2011.06.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Prospective Pathologic Study to Define

A Prospective Pathologic Study to Define the Clinical Target Volume for Partial Breast Radiation Therapy in Women With Early Breast Cancer

✍ Brandon T. Nguyen; Siddhartha Deb; Stephen Fox; Prudence Hill; Marnie Collins; B 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 230 KB

391 Higher Risk of Locoregional Recurren

391 Higher Risk of Locoregional Recurrences for Women Treated with Mastectomy Compared to Breast-Conserving Therapy in Postmenopausal Women with Early Breast Cancer Treated on the TEAM Trial

✍ M. van Hezewijk; E.T.M. Hille; H. Putter; D. Rea; A. Hasenburg; C. Markopoulos; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Corrigendum to “Vascular endothelial gro

Corrigendum to “Vascular endothelial growth factor is a strong predictor of early distant recurrences in a prospective study of premenopausal women with lymph-node negative breast cancer” [The Breast 17 (2008) 484–491]

✍ Barbro K. Linderholm; Sofia Gruvberger-Saal; Mårten Fernö; Pär-Ola Bendahl; Per 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 55 KB

A prospective, longitudinal study to inv

A prospective, longitudinal study to investigate the impact of changes in service provision for the follow-up of women (over 50 years) with primary breast cancer

✍ Pauline Hyman-Taylor; J. Robertson; K. Cox 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views